Skip to main content
Log in

Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

This experiment was designed to characterize the withdrawal syndrome produced by discontinuation of treatment with escalating, non-neurotoxic doses ofd-amphetamine (AMPH). AMPH withdrawal was associated with both transient and persistent changes in behavior and postmortem brain tissue catecholamine concentrations. During the first week of withdrawal rats showed a significant decrease in spontaneous nocturnal locomotor activity. This behavioral depression was most pronounced on the first 2 days after the discontinuation of AMPH pretreatment, was still evident after 1 week, but had dissipated by 4 weeks. Behavioral depression was not due to a simple motor deficit, because AMPH-pretreated animals showed a normal large increase in locomotion when the lights initially went out, but they did not sustain relatively high levels of locomotor activity throughout the night, or show the early morning rise in activity characteristic of controls. Behavioral depression was associated with a transient decrease in the concentration of norepinephrine (NE) in the hypothalamus, and a transient decrease in the ability of an AMPH challenge to alter dopamine (DA) concentrations in the caudateputamen and nucleus accumbens. AMPH pretreatment also produced persistent changes in brain and behavior. The persistent effects of AMPH were not evident in spontaneous locomotor activity, but were revealed by a subsequent challenge injection of AMPH. AMPH pretreated animals were markedly hyper-responsive to the stereotypy-producing effects of an AMPH challenge. This behavioral sensitization was not fully developed until 2 weeks after the discontinuation of AMPH pretreatment, but then persisted undiminished for at least 1 year. It is suggested that the transient changes in brain and behavior described here may represent an animal analogue of the “distress syndrome” seen in humans during AMPH withdrawal, which is associated with symptoms of depression and alterations in catecholamine function. On the other hand, persistent behavioral sensitization may be analogous to the enduring hypersensitivity to the psychotogenic effects of AMPH seen in former AMPH addicts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aghajanian GK (1978) Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 276:186–188

    Article  PubMed  Google Scholar 

  • Anisman H (1984) Vulnerability to depression: contribution of stress. In: Post RM, Ballenger JC (eds) Neurobiology of mood disorders. Williams & Wilkins, Baltimore, pp 407–431

    Google Scholar 

  • Antelman S (1988) Time-dependent sensitization as the cornerstone for a new approach to pharmacotherapy: drugs as foreign/stressful stimuli. Drug Dev Res 14:1–30

    Article  Google Scholar 

  • Antelman SM, Eichler AJ, Black CA, Kocan D (1980) Interchange-ability of stress and amphetamine in sensitization. Science 207:329–331

    PubMed  Google Scholar 

  • Berridge KC, Venier IL, Robinson TE (1989) Taste reactivity analysis of 6-hydroxydopamine-induced aphagia: implications for arousal and anhedonia hypotheses of dopamine function. Behav Neurosci 103:36–45

    Article  PubMed  Google Scholar 

  • Camp DM, Robinson TE (1988) Susceptibility to sensitization. II. The influence of gonadal hormones on enduring changes in brain monoamines and behavior produced by the repeated administration ofd-amphetamine or restraint stress. Behav Brain Res 30:69–88

    Article  PubMed  Google Scholar 

  • Carroll ME, Lac ST (1987) Cocaine withdrawal produces behavioral disruptions in rats. Life Sci 40:2183–2190

    Article  PubMed  Google Scholar 

  • Cassens G, Actor C, Kling M, Schildkraut JJ (1981) Amphetamine withdrawal: effects on threshold of intracranial reinforcement. Psychopharmacology 73:318–322

    Article  PubMed  Google Scholar 

  • Cassens G, Kuruc A, Orsulak PJ, Schildkraut JJ (1979) Amphetamine withdrawal: effects on brain levels of MHPG-SO4 in the rat. Commun Psychopharmacol 3:217–223

    PubMed  Google Scholar 

  • Castañeda E, Becker JB, Robinson TE (1988) The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro. Life Sci 42:2447–2456

    Article  PubMed  Google Scholar 

  • Commissiong JW (1985) Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity. Biochem Pharmacol 34:1127–1131

    Article  PubMed  Google Scholar 

  • Ellinwood EH (1972) Amphetamine psychosis: individuals, settings, and sequences. In: Ellinwood EH, Cohen S (eds) Current concepts on amphetamine abuse. US Government Printing Office, Washington D.C., pp 143–157

    Google Scholar 

  • Fibiger HC, Phillips AG (1981) Increased intracranial self-stimulation in rats after long-term administration of desipramine. Science 214:683–685

    PubMed  Google Scholar 

  • Gawin FH, Ellinwood EJ (1988) Cocaine and other stimulants. Actions, abuse, and treatment. N Engl J Med 318:1173–1182

    PubMed  Google Scholar 

  • Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C (1989) Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 46:117–121

    PubMed  Google Scholar 

  • Grant SJ, Galloway MP, Mayor R, Fenerty JP, Finkelstein MF, Roth RH, Redmond DJ (1985) Precipitated diazepam withdrawal elevates noradrenergic metabolism in primate brain. Eur J Pharmacol 107:127–132

    Google Scholar 

  • Heffner TG, Hartman JA, Seiden LS (1980) A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 13:453–456

    Article  PubMed  Google Scholar 

  • Herman ZS, Trzeciak H, Chrusciel TL, Kmieciak KK, Drybanski A, Sokola A (1971) The influence of prolonged amphetamine treatment and amphetamine withdrawal on brain biogenic amine content and behaviour in the rat. Psychopharmacologia 21:74–81

    Article  PubMed  Google Scholar 

  • Hitzemann RJ, Tseng LF, Hitzemann BA, Sampath KS, Loh HH (1977) Effects of withdrawal from chronic amphetamine intoxication on exploratory and stereotyped behaviors in the rat. Psychopharmacology 54:295–302

    Article  PubMed  Google Scholar 

  • Honma K, Honma S, Hiroshige T (1986) Disorganization of the rat activity rhythm by chronic treatment with methamphetamine. Physiol Behav 38:687–695

    Article  PubMed  Google Scholar 

  • Kazahaya Y, Akimoto K, Otsuki S (1989) Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo. Biol Psychiatry 25:903–912

    Article  PubMed  Google Scholar 

  • Klawans HL, Margolin DI (1975) Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders. Arch Gen Psychiatry 32:725–732

    PubMed  Google Scholar 

  • Kokkinidis L (1988) Neurochemical correlates of post-amphetamine depression and sensitization in animals. Anim Models Psychiatr Disord 2:148–173

    Google Scholar 

  • Kokkinidis L, Zacharko RM (1980) Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigm. Psychopharmacology 68:73–76

    Article  PubMed  Google Scholar 

  • Kokkinidis L, Zacharko RM, Anisman H (1986) Amphetamine withdrawal: a behavioral evaluation. Life Sci 38:1617–1623

    Article  PubMed  Google Scholar 

  • Kolta MG, Shreve P, De Souza V, Uretsky NJ (1985) Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology 24:823–829

    Article  PubMed  Google Scholar 

  • Kolta MG, Shreve P, Uretsky NJ (1989) Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens. Neuropharmacology 28:9–14

    Article  PubMed  Google Scholar 

  • Kramer J, Fischman V, Littlefield D (1967) Amphetamine abuse. JAMA 201:305–309

    Article  PubMed  Google Scholar 

  • Leith NJ, Barrett RJ (1976) Amphetamine and the reward system: evidence for tolerance and post- drug depression. Psychopharmacologia 46:19–25

    Article  PubMed  Google Scholar 

  • Leith NJ, Kuczenski R (1982) Two dissociable components of behavioral sensitization following repeated amphetamine administration. Psychopharmacology 76:310–315

    Article  PubMed  Google Scholar 

  • Lynch MA, Leonard BE (1978) Effect of chronic amphetamine administration on the behaviour of rats in the open field apparatus: reversal of post-withdrawal depression by two antidepressants. J Pharm Pharmacol 30:798–799

    PubMed  Google Scholar 

  • Lynch M, Kenny M, Leonard BE (1977) The effect of chronic administration ofd-amphetamine on regional changes in cate-cholamines in the rat brain. J Neurosci Res 3:295–300

    Article  PubMed  Google Scholar 

  • Magos L (1969) Persistence of the effect of amphetamine on stereotyped activity on rats. Eur J Pharmacol 6:200–201

    Article  PubMed  Google Scholar 

  • Maj J, Wedzony K, Klimek V (1987) Desipramine given repeatedly enhances behavioural effects of dopamine andd-amphetamine injected into the nucleus accumbens. Eur J Pharmacol 140:179–185

    Article  PubMed  Google Scholar 

  • McCown TJ, Barrett RJ (1980) Development of tolerance to the rewarding effects of self-administered (+)-amphetamine. Pharmacol Biochem Behav 12:137–141

    Article  PubMed  Google Scholar 

  • Pittendrigh CS, Daan S (1976) A functional analysis of circadian pacemakers in nocturnal rodents. V. Pacemaker structure: a clock for all seasons. J Comp Physiol 106:333–355

    Article  Google Scholar 

  • Post R (1980) Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life Sci 26:1275–1282

    Article  PubMed  Google Scholar 

  • Redmond DJ, Huang YH (1982) The primate locus coeruleus and effects of clonidine on opiate withdrawal. J Clin Psychiatry 25–29

  • Robinson TE (1988) Stimulant drugs and stress: factors influencing individual differences in the susceptibility to sensitization. In: Kalivas PW, Barnes CD (eds) Sensitization in the nervous system. Telford Press, Caldwell, New Yersey, pp 145–173

    Google Scholar 

  • Robinson TE (1990) The neurobiology of amphetamine psychosis: evidence from studies with an animal model. In: Nakazawa T (ed) Taniguchi Symposia on Brain Sciences, vol 14, Biological basis of schizophrenic disorders. Japan Scientific Societies Press, Tokyo (in press)

    Google Scholar 

  • Robinson TE, Becker JB (1982) Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur J Pharmacol 85:253–254

    Article  PubMed  Google Scholar 

  • Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 396:157–198

    Article  Google Scholar 

  • Robinson TE, Camp DM (1987) Long-lasting effects of escalating doses ofd-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion. Pharmacol Biochem Behav 26:821–827

    Article  PubMed  Google Scholar 

  • Robinson TE, Becker JB, Presty SK (1982) Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Res 253:231–241

    Article  PubMed  Google Scholar 

  • Robinson TE, Jurson PA, Bennett JA, Bentgen KM (1988) Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by past experience with (+)-amphetamine: a microdialysis study in freely moving rats. Br Res 462:211–222

    Article  Google Scholar 

  • Roth RH, Elsworth JD, Redmond DJ (1982) Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates. J Clin Psychiatry 42–46

  • Sato M, Chen CC, Akiyama K, Otsuki S (1983) Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry 18:429–440

    PubMed  Google Scholar 

  • Schildkraut JJ, Watson R, Draskoczy PR (1971) Amphetamine withdrawal: depression and MHPG excretion. Lancet II:485–486

    Article  Google Scholar 

  • Schmidt C, Sonsalla P, Hanson G, Peat M, Gibb J (1985) Methamphetamine-induced depression of monoamine synthesis in the rat: development of tolerance. J Neurochem 44:852–855

    PubMed  Google Scholar 

  • Schreiber H, Bell R, Conely L, Kufner M, Palet J, Wright L (1976) Diminished reaction to a novel stimulus during amphetamine withdrawal in rats. Pharmacol Biochem Behav 5:687–690

    Article  PubMed  Google Scholar 

  • Segal DS (1975) Behavioral and neurochemical correlates of repeatedd-amphetamine administration. Adv Biochem Psychopharmacol 13:247–262

    PubMed  Google Scholar 

  • Segal DS, Mandell AJ (1974) Long-term administration ofd-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 2:249–255

    Article  PubMed  Google Scholar 

  • Segal DS, Schuckit MA (1983) Animal models of stimulant-induced psychosis. In: Creese I (ed) Stimulants: neurochemical, behavioral and clinical perspectives. Raven Press, New York, pp 131–167

    Google Scholar 

  • Segal DS, Weinberger SB, Cahill J, McCunney SJ (1980) Multiple daily amphetamine administration: behavioral and neurochemical alterations. Science 207:905–907

    PubMed  Google Scholar 

  • Seiden LS, Ricaurte GA (1987) Neurotoxicity of methamphetamine and related drugs. In: Melzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 359–366

    Google Scholar 

  • Seltzer V, Tonge SR (1975) Methylamphetamine withdrawal as a model for the depressive state: antagonism of post-amphetamine depression by imipramine. J Pharm Pharmacol 27:16P

    Google Scholar 

  • Short PH, Shuster L (1976) Changes in brain norepinephrine associated with sensitization tod-amphetamine. Psychopharmacology 48:59–67

    Article  PubMed  Google Scholar 

  • Simpson DM, Annau Z (1977) Behavioral withdrawal following several psychoactive drugs. Pharmacol Biochem Behav 7:59–64

    Article  PubMed  Google Scholar 

  • Sorensen SM, Hattox S, Johnson SW, Bickford P, Murphy R, Freedman R (1985) Norepinephrine-dependent and independent mechanisms of persistent effects of amphetamine in rat cerebellum. Life Sci 36:2383–2389

    Article  PubMed  Google Scholar 

  • Tonge SR (1974) Noradrenaline and 5-hydroxytryptamine metabolism in six areas of rat brain during post-amphethamine depression. Psychopharmacologia 38:181–186

    Article  PubMed  Google Scholar 

  • Utena H (1966) Behavioral aberrations in methamphetamine-intoxicated animals and chemical correlates in the brain. In: Tokizane T, Schade J (eds) Progress in brain research, Vol. 21B, Coerrelative neurosciences: clinical studies. Elsevier, Amsterdam, pp 192–207

    Google Scholar 

  • Watson R, Hartmann E, Schildkraut JJ (1972) Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion. Am J Psychiatry 129:263–269

    PubMed  Google Scholar 

  • Winer BJ (1971) Statistical principles in experimental design. McGraw-Hill, New York

    Google Scholar 

  • Weiss RD (1988) Relapse to cocaine abuse after initiating desipramine treatment. JAMA 260:2545–2546

    Article  PubMed  Google Scholar 

  • Weiss JM, Simson PG (1986) Depression in an animal model: focus on the locus ceruleus. Ciba Found Symp 123:191–215

    PubMed  Google Scholar 

  • Weiss JM, Bailey WH, Pohorecky LA, Korzeniowski D, Grillione G (1980) Stress-induced depression of motor activity correlates with regional changes in brain norepinephrine but not in dopamine. Neurochem Res 5:9–22

    Article  PubMed  Google Scholar 

  • Wilcox RA, Robinson TE, Becker JB (1986) Enduring enhancement in amphetamine-stimulated striatal dopamine release in vitro produced by prior exposure to amphetamine or stress in vivo. Eur J Pharmacol 124:375–376

    Article  PubMed  Google Scholar 

  • Wise RA, Rompre P-P (1989) Brain dopamine and reward. Ann Rev Psychol 40:191–225

    Article  Google Scholar 

  • Yamada S, Kojima H, Yokoo H, Tsutsumi T, Takamuki K, Anraku S, Nishi S, Inanaga K (1988) Enhancement of dopamine release from striatal slices of rats that were subchronically treated with methamphetamine. Biol Psychiatry 24:399–408

    Article  PubMed  Google Scholar 

  • Zacharko R, Anisman H (1989) Pharmacological, biochemical, and behavioral analyses of depression: animal models. In: Koob G (ed) Animal models of depression. Birkhauser, Boston, pp 204–238

    Google Scholar 

  • Zacharko RM, Bowers WJ, Kelley MS, Anisman H (1984) Prevention of stressor-induced disturbances of self-stimulation by desmethylimipramine. Brain Res 321:175–179

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paulson, P.E., Camp, D.M. & Robinson, T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology 103, 480–492 (1991). https://doi.org/10.1007/BF02244248

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244248

Key words

Navigation